Efficacy, Safety and Tolerability of the Co-administration of NVA237 Plus Indacaterol Once Daily Versus Indacaterol Once Daily in Patients With Moderate to Severe Chronic Obstructive Pulmonary Disease (COPD)
Clinical trial NCT01604278 · COMPLETED
Trial details
- NCT number
- NCT01604278
- Sponsor
- Novartis Pharmaceuticals
- Status
- COMPLETED
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2012-05-01
- Primary completion
- 2013-01-01
- Enrollment
- 449
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.